ReviewDrug design, development and therapy2014

Drug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis -- focus on subcutaneous tocilizumab.

Yasuharu Nakashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.